Company news
Fagron Sa (EURONEXT:FAGR) news
Every Fagron Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Fagron N : NV, - Disclosure of transparency notifications from BlackRock, Inc.
May 19, 2026
Fagron N : update on FDA communication regarding the November 2025 inspection at Boston
May 15, 2026
Fagron shareholders approve all proposed resolutions at the General Meetings
May 11, 2026
Fagron N : NV, - Disclosure of transparency notification from BlackRock, Inc.
April 29, 2026
Pete Pharma and Fagron Enter Strategic Distribution Partnership to Expand Access to Pharmaceutical 3D Printing Across North America
April 16, 2026
Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026
April 10, 2026
Fagron reports solid first-quarter revenue of €263 million, reflecting 10% topline growth
April 9, 2026
Fagron increases share capital through exercise subscription rights
March 31, 2026
Fagron N : NV, - Disclosure of a transparency notification from Aberdeen Group plc
March 19, 2026
Fagron publishes its Annual Report 2025
March 6, 2026
Fagron completes acquisition of Vepakum
March 3, 2026
Fagron completes strategic acquisition of Pharmavit Europe, strengthening its leadership in high‑growth nutraceutical ingredients across ...
February 26, 2026
Fagron continues its outstanding performance in FY 2025 with 9.2% topline growth and 10.9% increase in REBITDA
February 12, 2026
Fagron obtains regulatory clearance for the acquisition of Vepakum in Brazil and completes the acquisition of Magilab in Hungary
February 5, 2026
Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America
January 12, 2026
Fagron announces the completion of Purifarma
January 6, 2026
Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone
December 19, 2025
Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business
November 24, 2025
Fagron completes share buy-back program
November 14, 2025
Fagron’s share buy-back program: Weekly update
November 7, 2025
Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook
October 9, 2025
Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions
October 6, 2025
Fagron announces the acquisition of UCP in North America and FDA inspection update
September 25, 2025
Fagron delivers strong performance with 11% topline growth and 12% increase in REBITDA for H1 2025
July 31, 2025
Fagron shareholders approve all voting items AGM
May 12, 2025